Using hyaluronic acid to protect, heal, and repair tissue and skin is Anika’s specialty. It also employs the acid in products to combat osteoarthritis.
Company Information
Location | Bedford, MA |
Industry | Pharmaceuticals |
Sector | Health Care |
Fortune 500 Rank | - |
Fortune 500 Profile | - |
Current Streak | 1 |
Years on List | 1 |
CEO | Charles H. Sherwood |
Website | http://www.anikatherapeutics.com |
Revenue, Net Income
Revenue Past Four Quarters | 87 |
Net Income Past Four Quarters | 27 |
Growth Rates
EPS 3 yr Annual Growth Rate | 57% |
Rev 3 yr Annual Growth Rate | 16% |
Total Return 3 yr Annual Rate | 34% |
Beat S&P 3 yr Total Return? | yes |
Rank
EPS Growth Rank | 41 |
Revenue Growth Rank | 99 |
Total Return Rank | 67 |